- ISIN
- US58510H1032
- CUSIP
- 58510H103
- Sector
- Consumer Cyclical
- Industry
- Personal Services
- IPO Date
- Dec 29, 2020
Highlights
- Market Cap
- $8.70M
- Enterprise Value
- $33.77M
- EPS (TTM)
- ¥26.26
- PE Ratio
- 6.77
- PEG Ratio
- 0.06
- Total Revenue (TTM)
- ¥8.93B
- Gross Profit (TTM)
- ¥2.86B
- EBITDA (TTM)
- ¥468.09M
- Year Range
- $0.90 - $4.45
- ROA (TTM)
- 4.99%
- ROE (TTM)
- 15.55%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
MRM Performance Chart
MEDIROM Healthcare Technologies Inc. (MRM) is down 43.3% since the beginning of the year. At $1 per share, MRM is trading 75.3% below its 52-week high of $4. Investors who bought $1,000 worth of MRM shares 5 years ago would now be looking at an investment worth $118.
Loading charts...
Returns By Period
MEDIROM Healthcare Technologies Inc. (MRM) has returned -43.30% so far this year and -26.41% over the past 12 months.
MEDIROM Healthcare Technologies Inc.
- 1D
- -5.17%
- 1M
- -13.39%
- YTD
- -43.30%
- 6M
- -49.77%
- 1Y
- -26.41%
- 3Y*
- -41.87%
- 5Y*
- -34.74%
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
MRM Monthly Returns History
Based on dividend-adjusted daily data since Dec 29, 2020, MRM's average daily return is +0.08%, while the average monthly return is -0.98%.
Historically, 34% of months were positive and 66% were negative. The best month was Apr 2025 with a return of +112.1%, while the worst month was Dec 2024 at -69.6%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.
On a daily basis, MRM closed higher 40% of trading days. The best single day was Aug 26, 2024 with a return of +135.9%, while the worst single day was Dec 10, 2024 at -41.4%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -23.71% | -7.43% | -18.25% | 3.57% | -1.72% | -3.51% | -43.30% | ||||||
| 2025 | -9.90% | -25.43% | -46.86% | 112.13% | 98.72% | -8.39% | -16.20% | 51.26% | 17.78% | -2.83% | -1.46% | -4.43% | 88.35% |
| 2024 | 4.90% | -0.50% | 2.85% | -9.61% | -7.93% | -23.29% | -6.12% | 43.75% | -43.29% | -7.10% | 21.64% | -69.62% | -81.99% |
| 2023 | 39.02% | 0.64% | -2.54% | -5.04% | -0.51% | -6.54% | 18.42% | -21.46% | 14.46% | -6.75% | -11.13% | 19.42% | 26.83% |
| 2022 | 8.05% | 4.74% | 7.30% | 4.90% | -9.21% | -14.57% | 7.53% | -5.13% | -0.82% | -2.15% | -3.38% | -21.15% | -25.48% |
| 2021 | -0.26% | -14.29% | -7.28% | 3.82% | -19.88% | 2.16% | -23.71% | -10.29% | 28.33% | -22.65% | 5.01% | -12.53% | -57.97% |
Benchmark Metrics
MEDIROM Healthcare Technologies Inc. has an annualized alpha of 14.61%, beta of 0.41, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since December 29, 2020.
- This stock participated in 179.35% of S&P 500 Index downside but only -37.37% of its upside - more exposed to losses than it benefited from rallies.
- Beta of 0.41 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 14.61%
- Beta
- 0.41
- R²
- 0.00
- Upside Capture
- -37.37%
- Downside Capture
- 179.35%
Return for Risk
Risk / Return Rank
MRM ranks 44 for risk / return — on par with similar stocks. You're getting a typical balance of risk and reward. Not a standout, but not a red flag either — a reasonable choice if other factors align with your goals.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for MEDIROM Healthcare Technologies Inc. (MRM) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MRM | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.17 | ||
| Sortino ratioReturn per unit of downside risk | -1.39 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.37 | -0.21 |
| Calmar ratioReturn relative to maximum drawdown | -0.38 | 2.78 | -3.17 |
| Martin ratioReturn relative to average drawdown | -0.62 | 12.44 | -13.06 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the MEDIROM Healthcare Technologies Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the MEDIROM Healthcare Technologies Inc. was 98.18%, occurring on Mar 28, 2025. The portfolio has not yet recovered.
The current MEDIROM Healthcare Technologies Inc. drawdown is 94.44%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2025 selloff2025 | -98.18%Mar 2025 | 4y 3mo | — | 5y 5moDec 2020 - now |
Drawdown Indicators
| MRM | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.18% | -56.78% | -41.40% |
Max Drawdown (1Y)Largest decline over 1 year | -69.05% | -9.10% | -59.95% |
Max Drawdown (3Y)Largest decline over 3 years | -95.05% | -18.90% | -76.15% |
Max Drawdown (5Y)Largest decline over 5 years | -97.19% | -25.43% | -71.76% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -94.44% | -1.80% | -92.64% |
Average DrawdownAverage peak-to-trough decline | -74.06% | -10.71% | -63.35% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.97% | 2.03% | +40.94% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of MEDIROM Healthcare Technologies Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how MEDIROM Healthcare Technologies Inc. is priced in the market compared to other companies in the Personal Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for MRM, comparing it with other companies in the Personal Services industry. Currently, MRM has a P/E ratio of 6.8. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for MRM compared to other companies in the Personal Services industry. MRM currently has a PEG ratio of 0.1. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for MRM relative to other companies in the Personal Services industry. Currently, MRM has a P/S ratio of 0.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for MRM in comparison with other companies in the Personal Services industry. Currently, MRM has a P/B value of 1.1. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with MRM
Add MEDIROM Healthcare Technologies Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with MRM